How often should you get a Pap (Papanicolau) test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How Often Should You Get a Pap Test?

For women aged 21-29 years, get a Pap test every 3 years; for women aged 30-65 years, get either a Pap test alone every 3 years or preferably a Pap test plus HPV test (co-testing) every 5 years. 1

Age-Specific Screening Intervals

Women Ages 21-29 Years

  • Begin screening at age 21, regardless of sexual activity history 1, 2
  • Screen with Pap test alone every 3 years 1
  • Do NOT use HPV testing in this age group for routine screening, as HPV infections are common and typically transient in younger women 1

Women Ages 30-65 Years

  • Preferred option: Pap test plus HPV co-testing every 5 years 1
  • Alternative option: Pap test alone every 3 years 1
  • The 5-year interval with co-testing is safe due to the increased sensitivity of the combined approach 1

Women Under Age 21

  • Do not screen, regardless of sexual activity 1
  • Cervical cancer incidence is extremely low (only 1-2 cases per 1,000 females aged 15-19 years) 2

Women Over Age 65

  • Stop screening if you have had adequate prior screening with normal results 1, 3
  • Adequate screening means 3 consecutive negative Pap tests OR 2 consecutive negative co-tests within the past 10 years, with the most recent test within 5 years 3
  • Once stopped, do not resume screening for any reason, even with a new sexual partner 3

Special Populations Requiring Different Intervals

After Hysterectomy

  • Stop screening if your cervix was removed and you have no history of high-grade precancerous lesions or cervical cancer 1
  • Continue screening if hysterectomy was performed for cervical cancer or precancerous lesions 4

High-Risk Women

Continue more frequent screening if you have: 1

  • History of cervical cancer or high-grade precancerous lesions
  • HIV infection or immunocompromised status
  • History of persistent high-risk HPV infection
  • Previous abnormal Pap results

For high-risk women, screening intervals should be determined by clinical judgment and may require annual testing 1

Critical Evidence Supporting These Intervals

The 3-year interval for Pap testing is strongly supported by evidence showing that annual screening (every 1-2 years) compared to every 3 years improves screening effectiveness by less than 5% 4, 1. This minimal benefit does not justify the increased costs, patient burden, and potential harms from more frequent testing.

For women aged 30-65, adding HPV testing allows safe extension to 5-year intervals because the combined approach has much higher sensitivity for detecting precancerous lesions 1.

Common Pitfalls to Avoid

Over-Screening

  • Annual Pap tests are not recommended for average-risk women 1
  • Despite guidelines, research shows 65% of women still get tested annually, and 81% expect to be screened again within 1 year 5, 6
  • Over-screening increases costs and potential harms (anxiety, unnecessary procedures) without meaningful benefit 1

Under-Screening High-Risk Groups

  • Women who are recent immigrants, uninsured, or without a usual healthcare source have significantly lower screening rates 5
  • An estimated 14 million eligible women aged 21-65 have not been screened within the past 3 years 5

Screening After Age 65

  • Do not continue screening in adequately screened women, as modeling shows continued testing reduces cervical cancer mortality by only 0.18% at age 65 and 0.06% at age 74 4, 3
  • The exception is women with inadequate prior screening or high-risk factors 3

Screening Too Young

  • Starting before age 21 leads to detection and treatment of transient HPV infections that would resolve spontaneously, causing unnecessary anxiety and procedures 2

Medicare Coverage

Medicare covers Pap testing at 3-year intervals for average-risk women, with annual screening allowed for high-risk women (those with abnormal Pap smears in the preceding 3 years or at high risk for cervical or vaginal cancer) 4, 1.

References

Guideline

Cervical Cancer Screening Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cervical Cancer Screening Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cessation of Pap Smear Screening in Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What are the guidelines for Human Papillomavirus (HPV) testing in clinics?
What is the recommended follow-up interval for a patient with a normal Pap (Papanicolau) test result?
What is the recommended assessment and plan for routine Pap (Papanicolau) smear and cervical cancer screening?
At what age should women start getting screened for Human Papillomavirus (HPV) with a Pap (Papanicolaou) test?
What are the recommended guidelines for Pap (Papanicolau) tests and Human Papillomavirus (HPV) testing for cervical cancer screening?
What is the recommended antibiotic regimen and duration for treating recurrent diverticulitis?
What is the recommended treatment for Tinea corporis (ringworm of the body)?
What is the management plan for postpartum coronary artery dissection?
Why is hydromorphone preferred over morphine in the management of pancreatitis?
What is the best course of action for a patient with Hypertension (HTA), Dyslipidemia (DLP), Type 2 Diabetes Mellitus (DM 2), Hypothyroidism, and knee/hip osteoarthritis, taking Atorvastatina (Atorvastatin) 20mg, Hidroclorotiazida (Hydrochlorothiazide) 50mg, Metformina (Metformin) 850mg, Enalapril (Enalapril) 10mg, and Levotiroxina (Levothyroxine) 100mcg, who has poor adherence to treatment, and is experiencing worsening symptoms of nausea, vomiting, dysuria, eructation, headache, fever, shortness of breath, chest pain, and fatigue after starting Levofloxacino (Levofloxacin) 750mg daily for a urinary tract infection?
What is the management approach for a patient with positive tissue transglutaminase (tTG) antibodies but a negative biopsy for celiac disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.